Utah’s new nonprofit drug company will offer two antibiotics that are sometimes in limited supply as its first products.
The company hopes to alleviate shortages and stabilize prices by ensuring a steady supply of critical, generic drugs to some 900 hospitals nationwide.
Civica Rx, which launched last month in Lehi, announced this week that it had partnered with the Danish drug manufacturer Xellia to supply vancomycin and daptomycin, two antibiotics used to treat life-threatening infections, including drug-resistant staph infections.
“We will have a direct impact on patient safety and public health by providing consistent access to antibiotics that are important treatment options in the management of difficult-to-treat and life-threatening infections," Civica CEO Martin VanTrieste said in a news statement.